 The intent of the protocol is to assess health-related quality-of-life HRQOL in men treated for localized prostate cancer with 1 of 6 established management alternatives: external XRTor interstitial radiotherapy IRT, open radical prostatectomy RP, laparoscopic radical prostatectomy LRP, combined radiotherapy and brachytherapy Combined RT or watchful waiting WW. HRQOL is an important aspect of any treatment for prostate cancer due to the beliefs by many that cancer control rates are similar across common modalities and HRQOL reduction from treatment is substantial 1-5. Therefore, HRQOL appears to occupy a central role in the decision making process related to treatment selection. 